Table 1.
Baseline patient characteristics n (%)
| Characteristics | Value |
| Age, median (range), yr | 50 (20-87) |
| Gender | |
| Male | 150 (50) |
| Female | 150 (50) |
| Symptoms | |
| Abdominal burn | 152 (50.70) |
| Heart burn | 37 (12.30) |
| Dyspepsia | 33 (11) |
| Past medical history | |
| Hypertension | 81 (27) |
| Dyslipidemia | 53 (17.7) |
| Diabetes mellitus | 36 (12) |
| Hypothyroidism | 9 (3) |
| Social habits | |
| Smoking | 126 (42) |
| Exercise | 98 (32.7) |
| Alcohol intake | 62 (20.7) |
| Medication history | |
| Anti hypertensives | 86 (28.7) |
| Anti dyslipidemics | 54 (18) |
| Oral hypoglycemics | 28 (9.3) |
| Sedatives | 15 (5) |
| Anti-depressants | 16 (5.3) |
| PPIs1 | 155 (51.7) |
| Indications for PPI use | |
| Gastritis | 21 (13.5) |
| GERD | 48 (31) |
| GI ulcer | 10 (6.5) |
| Undocumented diagnosis | 76 (49) |
1
Proton pump inhibitors used: Rabeprazole (47%), esomeprazole (33%), omeprazole (17%), others (3%). GERD: Gastroesophageal reflux disease; PPIs: Proton pump inhibitors; GI: Gastrointestinal.